This lack of a significant difference was attributed to the fact that the p16 protein did not exhibit widespread cytoplasmic and nuclear presentation in the hypopharyngeal tumour cells and, therefore, did not have significant oncogenic effects in HPC. Here, CDKN2A is linked to neoplasm.